ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 275 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $251,000 | +796.4% | 15,097 | +26.9% | 0.01% | +700.0% |
Q2 2021 | $28,000 | -86.4% | 11,900 | -95.2% | 0.00% | -90.9% |
Q1 2021 | $206,000 | +261.4% | 246,200 | +1779.4% | 0.01% | +266.7% |
Q4 2019 | $57,000 | +111.1% | 13,100 | +1.6% | 0.00% | +50.0% |
Q1 2019 | $27,000 | +440.0% | 12,900 | -35.5% | 0.00% | – |
Q4 2018 | $5,000 | -72.2% | 20,000 | +60.0% | 0.00% | -100.0% |
Q3 2018 | $18,000 | -98.6% | 12,500 | -87.1% | 0.00% | -98.4% |
Q2 2018 | $1,266,000 | +2045.8% | 96,537 | +248.5% | 0.06% | +2000.0% |
Q1 2017 | $59,000 | -37.2% | 27,700 | -95.0% | 0.00% | -25.0% |
Q4 2016 | $94,000 | +4600.0% | 556,300 | +5463.0% | 0.00% | – |
Q3 2016 | $2,000 | -92.0% | 10,000 | -38.7% | 0.00% | -100.0% |
Q2 2016 | $25,000 | -98.8% | 16,300 | -97.3% | 0.00% | -99.3% |
Q1 2016 | $2,095,000 | +14864.3% | 612,530 | +5519.5% | 0.15% | +15200.0% |
Q4 2015 | $14,000 | -97.7% | 10,900 | -54.9% | 0.00% | -94.7% |
Q4 2013 | $604,000 | -32.9% | 24,155 | -26.3% | 0.02% | -34.5% |
Q3 2013 | $900,000 | – | 32,765 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |